Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
At a key investor conference, Micron revealed strategic moves and market signals that could alter its trajectory. Her...
Stocks moved sharply in both directions on Tuesday as investors weighed the risk of broader conflict in the Middle Ea...
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
A new wave of crypto treasuries aims to simplify bitcoin ownership for big firms. This articleexplores how Strategy's...
With a high-stakes Xi meeting on the horizon, President Trump has launched a calculated charm offensive, attracting t...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
A major fund trimmed its ACI Worldwide position, nudging the stock to trail the S&P 500 by a noticeable gap. This sto...
Analysts say Microsoft’s AI push is unlikely to threaten dividend safety inside Vanguard’s Dividend Appreciation ETF ...
Wendy's 2026 earnings kickoff for Q1 sheds light on growth drivers, pricing power, and franchise dynamics. This guide...
A five-month run lifted Taiwan’s ETF well ahead of the S&P 500, turning a $10,000 stake into $16,178 as semiconductor...
SpaceX just surpassed Amazon’s market cap on the third day of public trading, triggering a dramatic shift in tech sto...